Johnson Financial Group, Inc. Vericel Corp Transaction History
Johnson Financial Group, Inc.
- $2.06 Billion
- Q2 2024
A detailed history of Johnson Financial Group, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 16 shares of VCEL stock, worth $768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$768% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
270Shares Held
49.1MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$387 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.42MShares$212 Million4.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$119 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.08MShares$99.7 Million1.21% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.27B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...